Photodynamic Therapy for Keratinocytic Precancerous Lesions and Non-Melanoma Skin Cancer: A Narrative Review
Open Access
- 18 July 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (14) , 6396
Abstract
Photodynamic therapy (PDT) is a cornerstone non-invasive modality for keratinocytic precancers and non-melanoma skin cancer (NMSC), leveraging selective photosensitizer accumulation, light activation, and reactive oxygen species (ROS) generation. This narrative review synthesized literature from major databases (2010–2025) to comprehensively evaluate PDT’s molecular mechanisms, innovative optimization protocols, and clinical efficacy across actinic keratosis (AK), field cancerization, Bowen’s disease (BD), basal cell carcinoma (BCC), and invasive squamous cell carcinoma (cSCC). The evidence highlights frontline clinical maturity and excellent cosmetic outcomes for superficial lesions (AK, field cancerization, superficial BCC, and BD), with daylight PDT offering a virtually painless alternative for widespread dysplasia. However, therapeutic reliability decreases in thick nodular, pigmented, or high-risk lesions due to optical barriers and tissue hypoxia. To overcome these limitations, advanced physical and chemical enhancements—such as ablative fractional lasers, iron chelators, epigenetically enhanced PDT (ePDT), and targeted nanocarriers—are actively reshaping drug delivery and cellular susceptibility. Furthermore, cyclic PDT serves as an indispensable tissue-sparing intervention for organ transplant recipients and Gorlin syndrome patients. In conclusion, while PDT is highly effective for superficial neoplasias, precise histopathological stratification and the integration of nanomedicine are critical to overcoming current biological barriers in aggressive dermatological malignancies.Keywords
Funding Information
- Ministero della Salute
This publication has 64 references indexed in Scilit:
- Retrospective chart review and clinical experience of using fully ablative carbon dioxide laser assisted photodynamic therapy to treat basal cell carcinoma with 2 year outcomesLasers in Medical Science, 2026
- Successful Photodynamic Therapy for a Case of Cutaneous Squamous Cell Carcinoma With Difficulty in Primary Healing After SurgeryClinical Case Reports, 2025
- Expert consensus-based recommendations on the use of photodynamic therapy in actinic keratosis patientsJAAD International, 2025
- Developing Chlorin/Arylaminoquinazoline Conjugates with Nanomolar Activity for Targeted Photodynamic Therapy: Design, Synthesis, SAR, and Biological EvaluationJournal of Medicinal Chemistry, 2025
- Photodynamic therapy for the treatment of primary cutaneous B-cell marginal zone lymphoma: A series of 4 patientsJAAD Case Reports, 2023
- Advances in Photodynamic Therapy for the Treatment of Actinic Keratosis and Nonmelanoma Skin Cancer: A Narrative ReviewDermatology and Therapy, 2023
- A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: Bilaterally controlled, randomized trial of simultaneous versus conventional illuminationJournal of the American Academy of Dermatology, 2020
- Topical treatments and photodynamic therapy for actinic keratosis of the face and scalpCochrane Database of Systematic Reviews, 2019
- Photodynamic therapy for skin cancer: How to enhance drug penetration?Journal of Photochemistry and Photobiology B: Biology, 2019
- Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison studyPhotodiagnosis and Photodynamic Therapy, 2018